Defining neuronal responses to the neurotropic parasite <i>Toxoplasma gondii</i>

A select group of pathogens infects neurons in the brain. Prior dogma held that neurons were "defenseless" against infecting microbes, but many studies suggest that neurons can mount anti-microbial defenses. However, a knowledge gap in understanding how neurons respond <i>in vitro</i> and <i>in vivo</i> to different classes of microorganisms remains. To address this gap, we compared a transcriptional data set derived from primary neuron cultures (PNCs) infected with the neurotropic intracellular parasite <i>Toxoplasma gondii</i> with a data set derived from neurons injected with <i>T. gondii</i> protein <i>in vivo</i>. These curated responses were then compared to the transcriptional responses of PNCs infected with the single-stranded RNA viruses, West Nile virus or Zika virus. These analyses highlighted a conserved response to infection associated with chemokines (<i>Cxcl10, Ccl2</i>) and cytokines (interferon signaling). However, <i>T. gondii</i> had diminished IFN-α signaling <i>in vitro</i> compared to the viral data sets and was uniquely associated with a decrease in neuron-specific genes (<i>Snap25</i>, <i>Slc17a7</i>, <i>Prkcg</i>). These data underscore that neurons participate in infection-induced neuroinflammation and illustrate that neurons possess both pathogen-specific and pathogen-conserved responses.IMPORTANCEThough neurons are commonly the target of pathogens that infect the central nervous system (CNS), few data sets assess the neuronal response to infection. This paucity of data is likely because neurons are perceived to have diminished immune capabilities. However, to understand the role of neurons in neuroinflammation and their immune capabilities, their responses must be investigated. Here, we analyzed publicly accessible, neuron-specific data sets to compare neuron responses to a eukaryotic pathogen vs two Orthoflaviviruses. A better understanding of neuron responses to different infections will allow us to develop methods for inhibiting pathways that lead to neuron dysfunction, enhancing those that limit pathogen survival, and mitigating infection-induced damage to the CNS.